Genetics of inherited cardiomyopathies

References

• Richardson P, McKenna W Bristow M et al. Report of the 1995 World Health Organization/International Society and Federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 93(5), 841–842 (1996).
   Google Scholar
• Cohn JN, Bristow MR, Chien KR et al Report of the National Heart, Lung, and Blood Institute Special Emphasis Panelon Heart Failure Research. Circulation 95(4), 76–80 (1997).
   PubMedGoogle Scholar
• Boucek MM, Faro A, Novick RJ et al. The registry of the International Society for Heart and Lung Transplantation: fourth official pediatric report (2000). J. Heart Lung Transplant. 20(1), 39–52 (2001).
   Google Scholar
• Towbin JA. Myocardial Disease. In: Pediatric Cardiovascular Medicine. Moller JH, Hoffmann JE (Eds), Churchill Livingstone, NY, USA 753–767 (2000).
   Google Scholar
• Hunt SA, Baker DW, Chin MH et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J. Heart Lung Transplant. 21(2), 189–203 (2002).
   PubMedGoogle Scholar
• Codd MB, Sugrue DD, Gersh BJ, Melton LJd. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975–1984. Circulation 80(3), 564–572 (1989).
   PubMed Web of Science ®Google Scholar
• Arola A, Jokinen E, Ruuskanen 0 et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am. J. EpidemioL 146(5), 385–393 (1997).
   PubMedGoogle Scholar
• Arola A, Tuominen J, Ruuskanen 0, Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 101(3 Pt 1), 369–376 (1998).
   PubMedGoogle Scholar
• Lipshultz SE, Sleeper LA, Towbin JA et alThe incidence of pediatric cardiomyopathy in two regions of the USA. N Eng1J. Med 348(17), 1647–1655 (2003).
   Google Scholar
• •Detailed analysis of the incidence of pediatric cardiomyopathy in the USA.
   Google Scholar
• Levin HR, Oz MC, Chen JM et al. Reversal of chronic ventricular dilation in patients with end stage cardiomyopathy by prolonged mechanical unloading. Circulation 91(11), 2717–2720 (1995).
   PubMedGoogle Scholar
• Heiman DN, Maybaum SW Morales DL et al. Recurrent remodeling after ventricular assistance: is long-term myocardial recovery attainable? Ann. Thorac. Surg. 70(4), 1255–1258 (2000).
   PubMedGoogle Scholar
• Nugent AW, Daubeney PEF, Chondros P et al. The epidemiology of childhood cardiomyopathy in Australia. N Eng1J. Med 348(17), 1639–1646 (2003).
   Google Scholar
• •Detailed analysis of the incidence of pediatric cardiomyopathy in Australia.
   Google Scholar
• Felker GM, Thompson RE, Hare JM et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Eng1J. Med. 342(15), 1077–1084 (2000).
   Google Scholar
• •Comprehensive analysis of the underlying etiologies of cardiomyopathies and the relationship between the etiology and disease outcome.
   Google Scholar
• Matitiau A, Perez-Atayde A, Sanders SP et al. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 90(3), 1310–1318 (1994).
   PubMedGoogle Scholar
• Towbin JA. Pediatric myocardial disease. Pediatr. Clin. North Am. 46(2), 289–312 (1999).
   PubMedGoogle Scholar
• Towbin JA, Lipshultz SE. Genetics of neonatal cardiomyopathy. Curr. Opin. CardioL 14(3), 250–262 (1999).
   PubMedGoogle Scholar
• Michels VV, Moll PP, Miller FA et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J. Med 326(2), 77–82 (1992).
   Google Scholar
• Grunig E, Tasman JA, Kucherer H et al. Frequency and phenotypes of familial dilated cardiomyopathy. J. Am. Coll CardioL 31(1), 186–194 (1998).
   PubMedGoogle Scholar
• Kelly DR Strauss AW. Inherited cardiomyopathies. N Engl. J. Med. 330(13), 913–919 (1994).
   PubMedGoogle Scholar
• Mestroni L, Krajinovic M, Severini GM et al. Molecular genetics of dilated cardiomyopathies. Eur. Heart J. 16(Suppl. 0), 5–9 (1995).
   PubMedGoogle Scholar
• Keeling PJ, Gang Y, Smith G et al. Familial dilated cardiomyopathy in the United Kingdom. Br. Heart J. 73(5), 417–421 (1995).
   PubMedGoogle Scholar
• Towbin JA, Bowles NE. The failing heart. Nature 415(6868), 227–233 (2002).
   PubMedGoogle Scholar
• Towbin JA, Hejtmancik JF, Brink P et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87(6), 1854–1865 (1993).
   PubMedGoogle Scholar
• •First gene identified for dilated cardiomyopathy.
   Google Scholar
• Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51(6), 919–928 (1987).
   PubMed Web of Science ®Google Scholar
• Muntoni F, Cau M, Ganau A et al. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J. Med. 329(13), 921–925 (1993).
   PubMedGoogle Scholar
• Milasin J, Muntoni F, Severini GM et al. A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum. MoL Genet. 5(1), 73–79 (1996).
   PubMedGoogle Scholar
• Ortiz-Lopez R, Li H, Su J, Goytia V, Towbin JA. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation 95(10), 2434–2440 (1997).
   PubMedGoogle Scholar
• Feng J, Yan J, Buzin C, Towbin J, Sommer S. Mutations in the dystrophin gene are associated with sporadic dilated cardiomyopathy. Mol. Genet. Metab. 77 (1–2),119 (2002).
   Google Scholar
• Feng J, Yan JY, Buzin CH, Sommer SS, Towbin JA. Comprehensive mutation scanning of the dystrophin gene in patients with nonsyndromic X-linked dilated cardiomyopathy. J. Am. Coll. CardioL 40(6), 1120–1124 (2002).
   PubMedGoogle Scholar
• Bione S, D'Adamo P, Maestrini E et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nature Genet. 12(4), 385–389 (1996).
   PubMed Web of Science ®Google Scholar
• •Identification of the genetic cause of Barth Syndrome.
   Google Scholar
• Barth PG, Scholte HR, Berden JA et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J. NeuroL 62(1–3), 327–355 (1983).
   Google Scholar
• Kelley RI, Cheatham JP, Clark BJ et al. X- linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J. Pediatr. 119(5), 738–747 (1991).
   PubMedGoogle Scholar
• Schlame M, Towbin JA, Heerdt PM et al. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann. Neural. 51(5), 634–637 (2002).
   PubMedGoogle Scholar
• Bione S, Maestrini E, Rivella S et al. Identification of a novel X-linked gene responsible for Emery—Dreifuss muscular dystrophy. Nature Genet. 8(4), 323–327 (1994).
   PubMed Web of Science ®Google Scholar
• Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280(5364), 750–752 (1998).
   Google Scholar
• •Identification of the first gene for autosomal dominant dilated cardiomyopathy, confirming the link between the cardiomyocyte architecture and the disease.
   Google Scholar
• Li D, Tapscoft T, Gonzalez 0 et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100(5), 461–464 (1999).
   Google Scholar
• Tsubata S, Bowles KR, Vatta M et al. Mutations in the human g-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J. Clin. Invest. 106(5), 655–662 (2000).
   Google Scholar
• Barresi R, Di Blasi C, Negri T et al. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by /3-sarcoglycan mutations. J. Med. Genet. 37(2), 102–107 (2000).
   PubMed Web of Science ®Google Scholar
• Kamisago M, Sharma SD, DePalma SR et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N EngL J. Med. 343(23), 1688–1696 (2000).
   PubMedGoogle Scholar
• Olson TM, Kishimoto NY, Whitby FG, Michels VV. Mutations that alter the surface charge of a-tropomyosin are associated with dilated cardiomyopathy. J. MoL Cell. CardioL 33(4), 723–732 (2001).
   PubMedGoogle Scholar
• Gerull B, Gramlich M, Atherton J et al. Mutations of TT1V, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nature Genet. 30(2), 201–204 (2002).
   PubMedGoogle Scholar
• Olson TM, Illenberger S, Kishimoto NY et al. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 105(4), 431–437 (2002).
   Google Scholar
• Daehmlow S, Erdmann J, Knueppel T et al Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 298(1), 116-120(2002).
   PubMedGoogle Scholar
• Schmitt JP, Kamisago M, Asahi M et al Dilated cardiomyopathy and heart failure caused by a mutation in phvholamban. Science 299(5611), 1410–1413 (2003).
   Google Scholar
• ••Identification of a gene encoding an ionchannel associated with dilated cardiomyopathy and the first animal model expressing a human dilated cardiomyopathy (DCM) mutation.
   Google Scholar
• Knoll R, Hoshijima M, Hoffman HM et al The cardiac mechanical stretch sensor machinery involves a Z-disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111(7), 943–955 (2002).
   PubMedGoogle Scholar
• ••Identification of the role of the Z-disk as partof the cardiac mechanical stretch sensor and defects in this sensor as a cause of DCM.
   Google Scholar
• Mohapatra B, Jimenez S, Lin JH et al Mutations in the Muscle LIM protein and a-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. MoL Genet. Metab. 80,207–215 (2003).
   PubMed Web of Science ®Google Scholar
• Vatta M, Mohapatra B, Jimenez S et al Mutations in cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J. Am. ColL CardioL 42, 2014–2027 (2003).
   PubMed Web of Science ®Google Scholar
• Arimura T, Hayashi T, Terada H et al A opher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J BioL Chem. 279(8), 6746–6752 (2003).
   Google Scholar
• Mogensen J, Klausen IC, Pedersen AK et al a-cardiac actin is a novel disease gene in fmilial hypertrophic cardiomyopathy .j Clin. Invest. 103(10), R39—R43 (1999).
   Google Scholar
• Morimoto S, Lu Q-W Harada K et al Ca2+- desensitizing effect of a deletion mutation 81{210 in cardiac troponin Tthat causes familial dilated cardiomyopathy. Proc. Nail Acad Sci. 022628899 (2002).
   Google Scholar
• Thierfelder L, Watkins H, MacRae G et al tropomyosin and cardiac troponin Tmutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77(5), 701–712 (1994).
   Google Scholar
• Murphy RT, Mogensen J, Shaw A et al. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet 363(9406), 371–372 (2004).
   Google Scholar
• Dalakas MC, Park KY, Semino-Mora C et al. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N EngL J. Med. 342(11), 770–780 (2000).
   Google Scholar
• Goldfarb LG, Park KY, Cervenakova L et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nature Genet. 19(4), 402–403 (1998).
   Google Scholar
• Munoz-Marmol AM, Strasser G, Isamat M et al. A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc. Nad Acad. Sci. USA 95(19), 11312–113127 (1998).
   Google Scholar
• Sjoberg G, Saavedra-Matiz CA, Rosen DR et al. A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum. MoL Genet. 8(12), 2191–2198 (1999).
   PubMedGoogle Scholar
• Hack AA, Groh ME, McNally EM. Sarcoglycans in muscular dystrophy. Microsc. Res. Tech. 48(3–4), 167–180 (2000).
   Google Scholar
• Arber S, Hunter JJ, Ross J Jr et al. MLP- deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88(3), 393–403 (1997).
   Google Scholar
• Arber S, Haider G, Caroni P. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 79(2), 221–231 (1994).
   PubMed Web of Science ®Google Scholar
• Sadler I, Crawford AW, Michelsen JW, Beckerle MC. Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton. J. Cell. BioL 119(6), 1573–1587 (1992).
   PubMedGoogle Scholar
• Nix DA, Beckerle MC. Nuclear-cytoplasmic shuttling of the focal contact protein, zyxin: a potential mechanism for communication between sites of cell adhesion and the nucleus. J. Cell. BioL 138(5), 1139–1147 (1997).
   PubMedGoogle Scholar
• Dubreuil RR Structure and evolution of the actin crosslinking proteins. Bioessays 13(5), 219–226 (1991).
   PubMedGoogle Scholar
• Itoh-Satoh M, Hayashi T, Nishi H et al. Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 291(2), 385–393 (2002).
   Google Scholar
• Faulkner G, Pallavicini A, Formentin E et al. ZASP: a new Z-band alternatively spliced PDZ-motif protein. J. Cell. BioL 146(2), 465–475 (1999).
   PubMed Web of Science ®Google Scholar
• Blanchard A, Ohanian V, Critchley D. The structure and function of a-actinin. J. Muscle Res. CelL MotiL 10(4), 280–289 (1989).
   PubMedGoogle Scholar
• Djinovic-Carugo K, Young P, Gautel M, Saraste M. Structure of the a-actinin rod: molecular basis for crosslinking of actin filaments. Cell 98(4), 537–546 (1999).
   PubMedGoogle Scholar
• Moncman CL, Wang K Targeted disruption of nebulette protein expression alters cardiac myofibril assembly and function. E. CelL Res. 273(2), 204–218 (2002).
   PubMedGoogle Scholar
• Pashmforoush M, Pomies P, Peterson KL et al Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy. Nature Med 7(5), 591-597(2001).
   PubMedGoogle Scholar
• Bang ML, Mudry RE, McElhinny AS et al Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies. j CelL BioL 153(2), 413–427 (2001).
   PubMed Web of Science ®Google Scholar
• Salmikangas P, van der Yen PF, Lalowski M et al Myotilin, the limb-girdle muscular dystrophy lA (LGMD1A) protein, crosslinks actin filaments and controls sarcomere assembly. Hum. MoL Genet. 12(2), 189–203 (2003).
   PubMedGoogle Scholar
• Bellin RI\4, Huiatt TW, Critchley DR, Robson RM. Synemin may function to directly link muscle cell intermediate filaments to both myofibrillar Z-lines and costameres. j BioL Chem. 276(34), 32330–32337 (2001).
   PubMedGoogle Scholar
• Srivastava D, Olson EN. A genetic blueprint for cardiac development. Nature 407(6801), 221–226 (2000).
   PubMed Web of Science ®Google Scholar
• Hein S, Kostin S, Heling A, Maeno Y, Schaper J. The role of the cytoskeleton in heart failure. Cardiovasc. Res. 45(2), 273–278 (2000).
   PubMed Web of Science ®Google Scholar
• Fatkin D, MacRae C, Sasaki T et al Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N EngL J Med 341(23), 1715–1724 (1999).
   Google Scholar
• •Identification of lamin A/C as one of the major genes underlying dilated cardiomyopathy associated with conduction disease.
   Google Scholar
• Brodsky GL, Muntoni F, Miocic S et al Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101(5), 473–476 (2000).
   Google Scholar
• Bienengraeber M, Olson TM, Selivanov VA et al ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nature Genet. 36(4), 382–387 (2004).
   PubMed Web of Science ®Google Scholar
• •Identification of the potential role of potassium channels in dilated cardiomyopathy associated with conduction disease.
   Google Scholar
• Holt I, Ostlund C, Stewart CL et al Effect of pathogenic missense mutations in lamin A on its interaction with emerin in vivo. J CelL Sci. 116(14), 3027–3035 (2003).
   PubMedGoogle Scholar
• Nikolova V, Leimena C, McMahon AC et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J. Clin. Invest. 113(3), 357–369 (2004).
   Google Scholar
• Sinagra G, Di Lenarda A, Brodsky GL et al. Current perspective new insights into the molecular basis of familial dilated cardiomyopathy. Ital. Heart J. 2(4), 280–286 (2001).
   PubMedGoogle Scholar
• Chen R, Tsuji T, Ichida F et al. Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction. Ma Genet. Metab. 77(4), 319–325 (2002).
   PubMed Web of Science ®Google Scholar
• Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 82(2), 507–513 (1990).
   PubMed Web of Science ®Google Scholar
• Ichida F, Hamamichi Y, Miyawaki T et al. Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background. J. Am. Coll. Cardiol 34(1), 233–240 (1999).
   PubMed Web of Science ®Google Scholar
• Bleyl SB, Mumford BR, Brown-Harrison MC et al. Xq28-linked noncompaction of the left ventricular myocardium: prenatal diagnosis and pathologic analysis of affected individuals. Am. J. Med. Genet. 72(3), 257–265 (1997).
   PubMedGoogle Scholar
• Ichida F, Tsubata S, Bowles KR et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 103(9), 1256–1263 (2001).
   PubMed Web of Science ®Google Scholar
• •Identification of the first gene for autosomal dominant left ventricular noncompaction.
   Google Scholar
• Grady RI\4, Grange RW, Lau KS et al. Role for a-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nature Cell. Biol. 1(4), 215–220 (1999).
   PubMedGoogle Scholar
• Hughes SE. The pathology of hypertrophic cardiomyopathy. Histopathology 44(5), 412–427 (2004).
   PubMed Web of Science ®Google Scholar
• Maron BJ. Hypertrophic cardiomyopathy. Lancet 350(9071), 127–133 (1997).
   PubMed Web of Science ®Google Scholar
• Towbin JA. Molecular genetics of hypertrophic cardiomyopathy. Curr. Cardiol Rep. 2(2), 134–140 (2000).
   PubMedGoogle Scholar
• Geisterfer-Lowrance AA, Kass S, Tanigawa G et al. A molecular basis for familial hypertrophic cardiomyopathy: a fl-cardiac myosin heavy chain gene missense mutation. Cell 62(5), 999–1006 (1990).
   Google Scholar
• •First gene identified for hypertrophic cardiomyopathy.
   Google Scholar
• Marian AJ, Salek L, Lutucuta S. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. Minerva Med. 92(6), 435–451 (2001).
   PubMedGoogle Scholar
• Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J. Mal Cell Cardia 33(4), 655–670 (2001).
   PubMed Web of Science ®Google Scholar
• Geier C, Perrot A, Ozcelik C et al. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 107(10), 1390–1395 (2003).
   PubMedGoogle Scholar
• Hayashi T, Arimura T, Ueda K et al Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 313(1), 178–184 (2004).
   PubMedGoogle Scholar
• Arad M, Seidman JG, Seidman CE. Phenotypic diversity in hypertrophic cardiomyopathy. Hum. Mal Genet. 11(20), 2499–2506 (2002).
   PubMedGoogle Scholar
• Ho CY, Lever HM, DeSanctis R et al Homozygous mutation in cardiac troponin implications for hypertrophic cardiomyopathy. Circulation 102(16), 1950–1955 (2000).
   Google Scholar
• Richard P, Charron P, Carrier L et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107(17), 2227–2232 (2003).
   PubMedGoogle Scholar
• •• Comprehensive mutation analysis of patients with hypertrophic cardiomyopathy, with the identification of individuals at high risk of severe disease and poor outcomes.
   Google Scholar
• Arbustini E, Fasani R, Morbini P et al. Coexistence of mitochondrial DNA and /3-myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure. Heart 80(6), 548–558 (1998).
   PubMedGoogle Scholar
• •Identification of both mitochondrial DNA and sarcomeric defects resulting in severe hypertrophic cardiomyopathy and poor disease outcome.
   Google Scholar
• Satoh M, Takahashi M, Sakamoto T et al Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem. Biophys. Res. Commun. 262(2), 411–417 (1999).
   Google Scholar
• Blair E, Redwood C, Ashrafian H et alMutations in the y2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mal Genet. 10(11), 1215–1220 (2001).
   PubMed Web of Science ®Google Scholar
• Gollob MH, Green MS, Tang AS-L et al. Identification of a gene responsible for familial Wolff—Parkinson—White syndrome. N Engl J. Med. 344(24), 1823–1831 (2001).
   PubMed Web of Science ®Google Scholar
• Campbell KP. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80(5), 675–679 (1995).
   PubMedGoogle Scholar
• Cox GF, Kunkel LM. Dystrophies and heart disease. Curr. Opin. Cardiol 12(3), 329–343 (1997).
   PubMed Web of Science ®Google Scholar
• Nigro V, de Sa Moreira E, Piluso G et al. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the 8-sarcoglycan gene. Nature Genet. 14(2), 195–198 (1996).
   PubMedGoogle Scholar
• Lim LE, Duclos F, Broux 0 et al fi-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nature Genet. 11(3), 257–265 (1995).
   Google Scholar
• Bonne G, Di Barletta MR, Varnous S et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery—Dreifuss muscular dystrophy. Nature Genet. 21(3), 285–288 (1999).
   PubMed Web of Science ®Google Scholar
• Nowak KJ, Wattanasirichaigoon D, Goebel HH et al. Mutations in the skeletal muscle a-actin gene in patients with actin myopathy and nemaline myopathy. Nature Genet. 23(2), 208–212 (1999).
   Google Scholar
• Michele DE, Albayya FP, Metzger JM. A nemaline myopathy mutation in a-tropomyosin causes defective regulation of striated muscle force production. J. Clin. Invest. 104(11), 1575–1581 (1999).
   Google Scholar
• D'Adamo P, Fassone L, Gedeon A et al. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am. J. Hum. Genet. 61(4), 862–867 (1997).
   PubMedGoogle Scholar
• Carlsson L, Thornell LE. Desmin-related myopathies in mice and man. Acta. Physiol Scand. 171(3), 341–348 (2001).
   PubMedGoogle Scholar
• Corrado D, Basso C, Thiene G et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J. Am. Coll. Cardiol 30(6), 1512–1520. (1997).
   PubMed Web of Science ®Google Scholar
• Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl. J. Med. 318(3), 129–133 (1988).
   PubMed Web of Science ®Google Scholar
• Furlanello F, Bertoldi A, Dallago M et al. Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia. Pacing Clin. Electrophysiol 21(1 Pt 2), 331–335 (1998).
   PubMedGoogle Scholar
• DaIla Volta S, Fameli 0, Maschio G. The clinical and hemodynamic syndrome of auricularisation of the right ventricle. (Apropos of four personal cases). Arch. Mal. Coeur Vaiss. 58(8), 1129–1143 (1965).
   PubMedGoogle Scholar
• Frank R, Fontaine G, Vedel J et al Electrocardiology of four cases of right ventricular dysplasia inducing arrhythmia. Arch. Mal. Coeur Vaiss. 71(9), 963–972 (1978).
   PubMedGoogle Scholar
• Fontaine G, Guiraudon G, Frank R et al. Arrhythmogenic right ventricular dysplasia and Uhl's disease. Arch. Mal. Coeur Vaiss. 75(4), 361–371 (1982).
   PubMedGoogle Scholar
• Tiso N, Stephan DA, Nava A et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. MoL Genet. 10(3), 189–194 (2001).
   PubMedGoogle Scholar
• •First gene identified for arrhythmogenic right ventricular dysplasia/cardiomyopathy.
   Google Scholar
• McKoy G, Protonotarios N, Crosby A et al Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355(9221), 2119–2124 (2000).
   PubMed Web of Science ®Google Scholar
• Norgett EE, Hatsell SJ, Carvajal-Huerta L et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum. MoL Genet. 9(18), 2761–2766 (2000).
   PubMed Web of Science ®Google Scholar
• Wallace DC. Mouse models for mitochondrial disease. Am. J. Med. Genet. 106(1), 71–93 (2001).
   PubMedGoogle Scholar
• Suomalainen A, Paetau A, Leinonen H et al. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 340(8831), 1319–1320 (1992).
   PubMedGoogle Scholar
• Taniike M, Fukushima H, Yanagihara I et al. Mitochondrial tRNA(Ile) mutation in fatal cardiomyopathy. Biochem. Biophys. Res. Commun. 186(1), 47–53 (1992).
   PubMed Web of Science ®Google Scholar
• Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ, Filiano JJ, Perez-Atayde A. Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy. J. Inherit. Metal,. Dis. 20(5), 674–680 (1997).
   PubMedGoogle Scholar
• Zeviani M, Gellera C, Antozzi C et al. Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR). Lancet 338(8760), 143–147 (1991).
   PubMed Web of Science ®Google Scholar
• Marin-Garcia J, Ananthakrishnan R, Gonzalvo A, Goldenthal MJ. Novel mutations in mitochondrial cytochrome b in fatal postpartum cardiomyopathy. J. Inherit. Metal,. Dis. 18(1), 77–78 (1995).
   PubMedGoogle Scholar
• Arbustini E, Diegoli M, Fasani R et al Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am. J. PathoL 153(5), 1501–1510 (1998).
   PubMedGoogle Scholar
• Leonard JV, Schapira AH. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 355(9200), 299–304 (2000).
   PubMed Web of Science ®Google Scholar
• Leonard JV, Schapira AH. Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet 355(9201), 389–394 (2000).
   PubMedGoogle Scholar
• Larsson NG, Holme E, Kristiansson B, Oldfors A, Tulinius M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns—Sayre syndrome. Pediatr Res. 28(2), 131–136 (1990).
   Google Scholar
• Zeviani M, Tiranti V, Piantadosi C. Mitochondrial disorders. Medicine (Baltimore) 77(1), 59–72 (1998).
   PubMedGoogle Scholar
• Tanaka M, Ino H, Ohno K et al. Mitochondrial mutation in fatal infantile cardiomyopathy. Lancet 336(8728), 1452 (1990).
   Google Scholar
• Christodoulou J, McInnes RR, Jay V et al Barth syndrome: clinical observations and genetic linkage studies. Am. J Med. Genet. 50(3), 255–264 (1994).
   PubMedGoogle Scholar
• Barth PG, Van den Bogert C, Bolhuis PA et al X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): respiratory-chain abnormalities in cultured fibroblasts. J. Inherit. Metab. Dis. 19(2), 157–160 (1996).
   PubMedGoogle Scholar
• Zeviani M, Spinazzola A. Mitochondrial disorders. Curr. 1VeuroL Neurosci. Rep. 3(5), 423–432 (2003).
   Google Scholar
• Petruzzella V, Tiranti V, Fernandez P et al Identification and characterization of human cDNAs specific to BCS1, PET112, SC01, COX15, and COX//, five genes involved in the formation and function of the mitochondrial respiratory chain. Genomics 54(3), 494–504 (1998).
   Google Scholar
• Zhu Z, Yao J, Johns T et al. SURF1, encoding a factor involved in the biogenesis of cytochrome C oxidase, is mutated in Leigh syndrome. Nature Genet. 20(4), 337–343 (1998).
   PubMedGoogle Scholar
• Jaksch M, Ogilvie I, Yao J et al. Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome C oxidase deficiency. Hum. MoL Genet. 9(5), 795–801 (2000).
   PubMedGoogle Scholar
• Papadopoulou LC, Sue CM, Davidson MM et al. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nature Genet. 23(3), 333–337 (1999).
   PubMed Web of Science ®Google Scholar
• Sue CM, Karadimas C, Checcarelli N et al Differential features of patients with mutations in two COX assembly genes, SURF-/ and SCO2. Ann. 1VeuroL 47(5), 589–595 (2000).
   Google Scholar
• Valnot I, von Kleist-Retzow JC, Barrientos A et al. A mutation in the human heme A:farnesyltransferase gene (COX10) causes cytochrome C oxidase deficiency. Hum. MoL Genet. 9(8), 1245–1249 (2000).
   PubMed Web of Science ®Google Scholar
• Tiranti V, Jaksch M, Hofmann S et al. Loss-of-function mutations of SURF-1 are specifically associated with Leigh syndrome with cytochrome C oxidase deficiency. Ann. NeuroL 46(2), 161–166 (1999).
   PubMedGoogle Scholar
• Jaksch M, Horvath R, Horn N et al Homozygosity (E140K) in 5CO2 causes delayed infantile onset of cardiomyopathy and neuropathy. Neurology 57(8), 1440–1446 (2001).
   PubMedGoogle Scholar
• Salviati L, Sacconi S, Rasalan MM et al. Cytochrome C oxidase deficiency due to a novel 5CO2 mutation mimics Werdnig—Hoffmann disease. Arch. NeuroL 59(5), 862–865 (2002).
   PubMedGoogle Scholar
• Sacconi S, Salviati L, Sue CM et al Mutation screening in patients with isolated cytochrome C oxidase deficiency. Pediatr Res. 53(2), 224–230 (2003).
   PubMedGoogle Scholar
• Orita M, Suzuki Y, Sekiya T, Hayashi K Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5(4), 874–879 (1989).
   PubMed Web of Science ®Google Scholar
• Underhill PA, Jin L, Lin AA et al Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res. 7(10), 996–1005 (1997).
   PubMedGoogle Scholar
• Underhill PA, Jin L, Zemans R, Oefner PJ, Cavalli-Sforza LL. A pre-Columbian Y chromosome-specific transition and its implications for human evolutionary history. Proc. Nad Acad Sci. USA 93(1), 196–200 (1996).
   PubMedGoogle Scholar
• Sanger F, Nicklen S, Coulson AR DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad Sci. USA 74(12), 5463–5467 (1977).
   PubMed Web of Science ®Google Scholar
• Erdmann J, Daehmlow S, Wischke S et al Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin. Genet. 64(4), 339–349 (2003).
   PubMedGoogle Scholar
• Waldmuller S, Freund P, Mauch S, Toder R, Vosberg HP. Low-density DNA microarrays are versatile tools to screen for known mutations in hypertrophic cardiomyopathy. Hum. Mutat. 19(5), 560–569 (2002).
   PubMedGoogle Scholar
• ••Analysis of the potential utility of DNAmicroarrays for the detection of genetic mutations associated with hypertrophic cardiomyopathy.
   Google Scholar
• Bowles NE. The molecular biology of dilated cardiomyopathy. Bur. Heart J. 4 (Suppl. I), 12–17 (2002).
   Google Scholar
• Clark KA, McElhinny AS, Beckerle MC, Gregorio CC. Striated muscle cytoarchitecture: an intricate web of form and function. Ann. Rev. Cell. Dev. Biol. 18,637–706 (2002).
   PubMed Web of Science ®Google Scholar
• Bowles KR, Abraham SE, Brugada R et al. Construction of a high-resolution physical map of the chromosome 10q22—q23 dilated cardiomyopathy locus and analysis of candidate genes. Genomics 67(2), 109–127 (2000).
   PubMedGoogle Scholar